These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27843595)

  • 1. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancer.
    Badora-Rybicka A; Nowara E; Starzyczny-Słota D
    ESMO Open; 2016; 1(2):e000039. PubMed ID: 27843595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y; Yan Q; Li S; Li B; Feng Y
    Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analysis of the prognostic value of the neutrophil/ lymphocyte ratio and the platelet/lymphocyte ratio among advanced endometrial cancer patients.
    Muzykiewicz KP; Iwanska E; Janeczek M; Glanowska I; Karolewski K; Blecharz P
    Ginekol Pol; 2021; 92(1):16-23. PubMed ID: 33448001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma.
    Kwon BS; Jeong DH; Byun JM; Lee TH; Choi KU; Song YJ; Suh DS; Kim KH
    J Cancer; 2018; 9(7):1127-1134. PubMed ID: 29675093
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic Value of The Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Platelet Count for Platinum-Sensitive Recurrent Epithelial Ovarian Cancer.
    Sowannakul A; Rodpenpear N; Ekbhum P; Tantitamit T
    Asian Pac J Cancer Prev; 2023 Nov; 24(11):3765-3771. PubMed ID: 38019234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
    Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
    Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
    Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
    Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment.
    Da L; Qu Z; Zhang C; Shen Y; Huang W; Zhang Y; Gu K
    Front Oncol; 2023; 13():1144875. PubMed ID: 37035159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy.
    D'Emic N; Engelman A; Molitoris J; Hanlon A; Sharma NK; Moeslein FM; Chuong MD
    J Gastrointest Oncol; 2016 Apr; 7(2):269-77. PubMed ID: 27034796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio in breast cancer patients.
    Huszno J; Kolosza Z
    Oncol Lett; 2019 Dec; 18(6):6275-6283. PubMed ID: 31788105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer.
    Wang X; Teng F; Kong L; Yu J
    Onco Targets Ther; 2016; 9():5761-5770. PubMed ID: 27703374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.
    Wu G; Yao Y; Bai C; Zeng J; Shi D; Gu X; Shi X; Song Y
    Thorac Cancer; 2015 May; 6(3):275-87. PubMed ID: 26273373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of the Pretreatment or Posttreatment NLR and PLR on the Response of First Line Chemotherapy and the Outcomes in Patients with Advanced Non-small Cell Lung Cancer].
    Yi F; Gu Y; Chen S; Liu Y; Yin W; Zhang Y; Cao B
    Zhongguo Fei Ai Za Zhi; 2018 Jun; 21(6):481-492. PubMed ID: 29945708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer.
    Wang H; Ding Y; Li N; Wu L; Gao Y; Xiao C; Jiang H; Zheng Y; Mao C; Deng J; Wang H; Xu N
    Front Oncol; 2020; 10():841. PubMed ID: 32637353
    [No Abstract]   [Full Text] [Related]  

  • 18. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer treated with definitive radiotherapy.
    Xia WY; Zhu XR; Feng W; Liu J; Wang JM; Lv CX; Zhang Q; Yu W; Cai XW; Fu XL
    Transl Lung Cancer Res; 2020 Oct; 9(5):1996-2007. PubMed ID: 33209619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-to-Lymphocyte Ratio and Platelet Count Predict Long-Term Outcome of Stage IIIC Epithelial Ovarian Cancer.
    Zhou M; Li L; Wang X; Wang C; Wang D
    Cell Physiol Biochem; 2018; 46(1):178-186. PubMed ID: 29587273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment Neutrophil-to-Lymphocyte Ratio: A Prognostic Biomarker of Survival in Patients With Epithelial Ovarian Cancer.
    John-Olabode SO; Okunade KS; Olorunfemi G; Soibi-Harry A; Rimi G; Osunwusi B; Okunowo A; Amaeshi L; Anorlu R
    Cureus; 2021 Jul; 13(7):e16429. PubMed ID: 34422466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.